1. NRG-BR002 finds no survival benefit from metastasis-directed ablation
Adding SBRT or surgery to systemic therapy did not improve progression-free or overall survival in randomized patients with oligometastatic breast cancer.
2. Left atrial and ventricular doses predict cardiac events after breast RT
After 16.5 years, left atrial dose was associated with major cardiac events, while left ventricular dose tracked with coronary disease.
3. BNCT shows high response but limited durability in head and neck cancer
In recurrent or unresectable head and neck cancer, BNCT achieved 80% response but only 42% two-year local control, with 2.1% fatal toxicity.
4. Regular surveillance is associated with better survival after nasopharyngeal cancer
Among 8,798 patients, regular surveillance, particularly distant-site imaging, was associated with better survival, although the retrospective design limits causal conclusions.
5. ESTRO-EPTN introduces new guidance for particle-therapy quality assurance
New recommendations support staged adoption of independent dose calculation and log-file QA, with phantom measurements reduced only after local validation.
That's the week. See you next Sunday.